Last edition
News about Global Pharma
Marksans Pharma’s UK subsidiary Relonchem has received UK MHRA approval for Baclofen 10 mg tablets, strengthening its presence in the UK pharmaceutical market.
Global Pharma | 19/03/2025 | By Manvi | 952
Kincell Bio Welcomes Larry Pitcher as Chief Operating Officer
Most recently, Larry was VP and GM for Catalent’s Gene Therapy Sites in MD, their largest operation, which accounted for a significant share of the company’s annual revenue.
Global Pharma | 19/03/2025 | By Aishwarya | 247
Shilpa Biologicals, mAbTree Biologics to Develop Immuno-Oncology Therapy
Under the terms of the agreement, Shilpa Biologicals will support the entire development process, including first-in-human clinical trials, while also ensuring long-term commercial supply through its Good Manufacturing Practice (GMP) manufacturing capabilities.
Global Pharma | 19/03/2025 | By Aishwarya | 799
Delpharm to Advance its Sterile Injectable Manufacturing Facility in Boucherville
The signing of a 10-year agreement between Delpharm and Sandoz establishes a foundation for ensuring a stable and reliable supply of critical medicines for Canadians, thereby enhancing the country's healthcare autonomy amid global supply chain disruptions.
Global Pharma | 19/03/2025 | By Aishwarya | 373
TAF 2025 Calls for Stricter Laws to Curb Drug Counterfeiting
In a major push to protect India’s industries, stakeholders at the 6th edition of the Traceability and Authentication Forum (TAF 2025) called for stricter anti-counterfeiting laws and advanced traceability measures.
Global Pharma | 19/03/2025 | By Aishwarya | 380
Clario, a provider of endpoint data solutions to the clinical trial industry, announced they have acquired NeuroRx, a company in imaging analysis with expertise in multiple sclerosis.
Global Pharma | 18/03/2025 | By Manvi | 332
Chance Pharma Receives New Funding to Develop Innovative Inhalation Therapies
Chance Pharma operates state-of-the-art production facilities compliant with FDA and EMA quality standards, underscoring its strong capabilities in both R&D and manufacturing.
Global Pharma | 18/03/2025 | By Aishwarya | 256
AstraZeneca Signs License Deal with Alteogen for ALT-B4
Under the terms of the agreement, AstraZeneca will acquire worldwide rights to use ALT-B4 to develop and commercialise subcutaneous formulations of several oncology assets.
Global Pharma | 18/03/2025 | By Aishwarya | 612
Curia Plans Expansion to Global Network of Sterile Fill-Finish Sites
Curia’s sterile fill-finish facility in Glasgow will add an integrated, isolator-based vial filling line and lyophilizer suitable for a broad range of drug product including highly potent capabilities, more than doubling current GMP batch size.
Global Pharma | 18/03/2025 | By Aishwarya | 756
Lupin Secures Tentative Approval from US FDA for Amifampridine Tablets
Lupin Ltd. has received tentative US FDA approval for its Amifampridine Tablets, 10 mg, a generic version of Firdapse, for treating Lambert-Eaton myasthenic syndrome.
Global Pharma | 17/03/2025 | By Manvi | 641
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy